Valeant to Acquire PharmaSwiss and Expand its Presence in Central and Eastern Europe
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 2 (Table of Contents)
Published: 16 Feb-2011
DOI: 10.3833/pdr.v2011.i2.1434 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to strengthen its operations in Central and Eastern Europe, Valeant Pharmaceuticals has agreed to acquire PharmaSwiss, a developer of branded generics and OTC products, for €350 M (US$478 M)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS